{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:32:54Z","timestamp":1788993174454,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1574,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.seizure.2008.11.001","type":"journal-article","created":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T09:14:56Z","timestamp":1229073296000},"page":"279-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities"],"prefix":"10.1016","volume":"18","author":[{"given":"Janine","family":"Beavis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Felce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2008.11.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2788.2000.00270.x","article-title":"Epilepsy and intellectual disability\u2014a review","volume":"44","author":"Bowley","year":"2000","journal-title":"J Intell Disabil Res"},{"key":"10.1016\/j.seizure.2008.11.001_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001504-200109000-00008","article-title":"Mortality in patients with intellectual disability and epilepsy","volume":"14","author":"Morgan","year":"2001","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.seizure.2008.11.001_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1754.2001.00644.x","article-title":"Cerebral palsy in Victoria, Australia: mortality and causes of death","volume":"37","author":"Reddihough","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.seizure.2008.11.001_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1528-1157.1996.tb00533.x","article-title":"Influence of epilepsy on mortality in mental retardation: an epidemiological study","volume":"37","author":"Forsgren","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2008.11.001_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.410260203","article-title":"A prospective study of sudden unexpected death in epilepsy","volume":"26","author":"Leestma","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2008.11.001_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.56.4.519","article-title":"Incidence and risk factors in sudden unexpected death in epilepsy. A prospective cohort study","volume":"56","author":"Walczak","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2008.11.001_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1059-1311(97)80033-7","article-title":"Learning disability and epilepsy 2: a review of available outcome measures and position statements on development priorities","volume":"6","author":"Espie","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.11.001_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1059-1311(97)80032-5","article-title":"Learning disability and epilepsy 1: towards common outcome measures","volume":"6","author":"Kerr","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.11.001_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/seiz.2001.0528","article-title":"Clinical guidelines for the management of epilepsy in adults with an intellectual disability","volume":"10","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.11.001_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jme.27.5.338","article-title":"The ethics of evidence based medicine: a randomised controlled trial of antipsychotic drugs for challenging behaviour in learning disability","volume":"27","author":"Ashcroft","year":"2001","journal-title":"J Medical Ethics"},{"key":"10.1016\/j.seizure.2008.11.001_bib11","series-title":"AAMR Adaptive Behavior Scale\u2014residential and community","author":"Nihira","year":"1993"},{"key":"10.1016\/j.seizure.2008.11.001_bib12","series-title":"The Aberrant Behavior Checklist","author":"Aman","year":"1986"},{"key":"10.1016\/j.seizure.2008.11.001_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1046\/j.1528-1157.2001.0420081043.x","article-title":"Development and validation of the Glasgow Epilepsy Outcome Scale (GEOS): a new instrument for measuring concerns about epilepsy in people with mental retardation","volume":"42","author":"Espie","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2008.11.001_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yebeh.2006.10.010","article-title":"The development and validation of the Epilepsy and Learning Disabilities Quality of Life (ELDQOL) scale","volume":"10","author":"Buck","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.11.001_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2003.12.005","article-title":"Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects","volume":"5","author":"Brodtkorb","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.11.001_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.yebeh.2006.01.003","article-title":"The impact of levetiracetam on challenging behavior","volume":"8","author":"Hurtado","year":"2006","journal-title":"Epilepsy Behav"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913110800246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913110800246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:37:57Z","timestamp":1761010677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913110800246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S105913110800246X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2008.11.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2008.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}